Member-only story

Antimicrotubule Agents in Chemotherapy: A Comprehensive Review

Norman Butler

·8.1k Followers· Follow

Published in Antimicrotubule Agents: Chemotherapy Comprehensive Review Series: 7

4 min read

52 View Claps

9 Respond

Save

Listen

Antimicrotubule agents are a class of chemotherapeutic drugs that target microtubules, which are essential for cell division, and disrupt their function, leading to cell death. Microtubules are long, thin, hollow cylinders made up of tubulin proteins. They are found in all eukaryotic cells and play a vital role in cell division, cell shape, and intracellular transport.

Antimicrotubule agents: Chemotherapy comprehensive review series: 7

Antimicrotubule agents: Chemotherapy comprehensive review series: book 7

by Maha Alkurdi

5 out of 5

Language	:	English
File size	:	444 KB
Text-to-Speech	:	Enabled
Screen Reader	:	Supported
Enhanced typesetting	:	Enabled
Print length	:	49 pages
Lending	:	Enabled

Antimicrotubule agents work by binding to tubulin and preventing it from polymerizing into microtubules. This leads to the disruption of microtubule dynamics and the inhibition of cell division. As a result, antimicrotubule agents are effective against cancer cells, which are characterized by rapid cell division.

Types of Antimicrotubule Agents

There are two main types of antimicrotubule agents:

Vinca alkaloids: Vinca alkaloids, such as vincristine, vinblastine, and vinorelbine, bind to tubulin and prevent it from polymerizing into microtubules. They are used to treat a variety of cancers, including leukemia, lymphoma, and breast cancer.
Taxanes: Taxanes, such as paclitaxel and docetaxel, bind to tubulin and stabilize microtubules, preventing them from depolymerizing. They are used to treat a variety of cancers, including ovarian cancer, breast cancer, and lung cancer.

Mechanism of Action

Antimicrotubule agents work by binding to tubulin and preventing it from polymerizing into microtubules. Microtubules are essential for cell division, as they form the mitotic spindle that separates the chromosomes during cell division. By disrupting microtubule dynamics, antimicrotubule agents prevent cell division and lead to cell death.

Clinical Applications

Antimicrotubule agents are used to treat a variety of cancers, including:

Leukemia
Lymphoma
Breast cancer
Ovarian cancer
Lung cancer
Prostate cancer

Antimicrotubule agents are typically given intravenously (IV) or orally. The dosage and frequency of administration will vary depending on the type of cancer being treated and the patient's individual needs.

Side Effects

The most common side effects of antimicrotubule agents include:

Myelosuppression (low blood counts)
Nausea and vomiting
Diarrhea
Hair loss
Peripheral neuropathy

The side effects of antimicrotubule agents can be managed with supportive care measures, such as antiemetics, antidiarrheals, and pain relievers.

Antimicrotubule agents are an important class of chemotherapeutic drugs that are used to treat a variety of cancers. They work by disrupting microtubule dynamics and inhibiting cell division. The most common side effects of antimicrotubule agents include myelosuppression, nausea and vomiting, diarrhea, hair loss, and peripheral neuropathy.

References